Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 20, 2018
Pharmacy Choice - Pharmacy News - September 20, 2018

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
9/19/18 - Global Parkinson's Disease Drugs Market 2018-2023: Recent Drug Approvals are Driving Growth
In January 2015, the US FDA approved an extended release formulation of levodopa/carbidopa. Recently in January 2018, Adamas Pharmaceuticals Inc. has launched Gocovri for the treatment of dyskinesia in people with Parkinson's, who are taking levodopa. -Generic Competition to Key Therapies- Restraining the Market.
9/19/18 - Global Parkinson's Disease Drugs Market 2018-2023: Recent Drug Approvals are Driving Growth - ResearchAndMarkets.com
In January 2015, the US FDA approved an extended release formulation of levodopa/carbidopa. Recently in January 2018, Adamas Pharmaceuticals Inc. has launched Gocovri for the treatment of dyskinesia in people with Parkinson's, who are taking levodopa. Key Highlights Generic Competition to Key Therapies- Restraining the Market Europe Holds the Large
9/19/18 - Teva Announces U.S. Approval of AJOVYTM Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing
JERUSALEM- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVYTM injection for the preventive treatment of migraine in adults. Migraine is a disabling neurological disease that affects more than 36 million people in the United States,' said Stephen Silberstein, MD, Director, Jefferson He
9/19/18 - UTILITY Receives Investigational New Drug Approval from US FDA
UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam. In May 2018 UTILITY announced the signature of an exclusive license agreement for the...
9/18/18 - AstraZeneca - US FDA approves LUMOXITI for certain patients with relapsed or refractory hairy cell leukemia
AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.
9/18/18 - FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis, a Rare Form of Juvenile Arthritis
South San Francisco- Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved the subcutaneous formulation of Actemra for the treatment of active systemic juvenile idiopathic arthritis in patients two years of age and older. 'Systemic juvenile idiopathic arthritis is a rare, debilitating diseas

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415